InvestorsHub Logo
Followers 115
Posts 11875
Boards Moderated 0
Alias Born 07/10/2014

Re: Biobillionair post# 118123

Tuesday, 11/21/2017 7:25:02 AM

Tuesday, November 21, 2017 7:25:02 AM

Post# of 423567
BB, you are great opening our eyes in the Regulatory side. Woodcock is making A&C decisions on Amarin that is costing huge health and tax payers money. She should have approved Anchor. Insignificant science based decision came from unskilled staff and this cannot be accepted. Agree Amarin management must push for AA using RWE guidance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News